Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (LXEO)
CUSIP: 52886X107
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common stock, par value $0.0001
- Shares outstanding
- 73,698,416
- Total 13F shares
- 26,566,622
- Share change
- +3,439,176
- Total reported value
- $426,105,401
- Price per share
- $16.04
- Number of holders
- 57
- Value change
- +$55,254,655
- Number of buys
- 37
- Number of sells
- 21
Quarterly Holders Quick Answers
What is CUSIP 52886X107?
CUSIP 52886X107 identifies LXEO - Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 52886X107:
Top shareholders of LXEO - Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
4.6%
|
3,369,147
|
$52,828,225 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.4%
|
2,540,785
|
$39,802,357 | — | 31 Mar 2024 | |
| D1 Capital Partners L.P. |
13F
|
Company |
3.4%
|
2,506,607
|
$39,303,598 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.4%
|
2,502,981
|
$38,884,020 | — | 31 Mar 2024 | |
| Omega Fund Management, LLC |
13F
|
Company |
3.2%
|
2,355,904
|
$36,940,575 | — | 31 Mar 2024 | |
| Longitude Capital Partners IV, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,567,100
|
$33,933,468 | — | 07 Nov 2023 | |
| Omega Fund VI, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,157,623
|
$28,520,755 | — | 07 Nov 2023 | |
| Novo Holdings A/S |
13F
|
Company |
2.2%
|
1,638,298
|
$25,688,513 | — | 31 Mar 2024 | |
| Invest A/s Lundbeckfond |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,835,959
|
$24,268,808 | — | 07 Nov 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.8%
|
1,322,736
|
$20,740,500 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
1.8%
|
1,322,277
|
$20,733,303 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
1.1%
|
801,716
|
$12,570,907 | — | 31 Mar 2024 | |
| Blackstone Inc. |
13F
|
Company |
0.94%
|
696,110
|
$10,915,005 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.9%
|
662,962
|
$10,395,243 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.9%
|
660,938
|
$10,363,508 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.81%
|
593,722
|
$8,725,853 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.65%
|
481,755
|
$7,553,919 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.62%
|
454,182
|
$7,121,574 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
197,799
|
$3,101,960 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.24%
|
175,000
|
$2,744,000 | — | 31 Mar 2024 | |
| CORNELL UNIVERSITY |
13F
|
Company |
0.17%
|
126,258
|
$1,979,725 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
112,215
|
$1,759,531 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.15%
|
111,186
|
$1,751,180 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
82,101
|
$1,287,344 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.08%
|
60,843
|
$954,018 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
49,177
|
$771,095 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
39,933
|
$626,149 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
28,323
|
$444,105 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
27,361
|
$429,020 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
23,559
|
$369,405 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
22,929
|
$359,527 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.02%
|
14,894
|
$233,538 | — | 31 Mar 2024 | |
| Paul McCormac |
3/4/5
|
Chief Technical Officer |
—
class O/S missing
|
17,349
|
$229,329 | — | 07 Nov 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
14,576
|
$229,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
13,944
|
$218,642 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.02%
|
13,478
|
$211,335 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.02%
|
12,051
|
$188,960 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
12,041
|
$188,803 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
10,367
|
$162,555 | — | 31 Mar 2024 | |
| CAXTON CORP |
13F
|
Company |
0.01%
|
10,319
|
$161,796 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
9,730
|
$152,561 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
5,953
|
$93,344 | — | 31 Mar 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
5,821
|
$91,273 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
5,271
|
$82,649 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
5,053
|
$79,231 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
4,781
|
$74,966 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
4,100
|
$64,288 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
3,369
|
$52,826 | — | 31 Mar 2024 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,800
|
$28,000 | — | 31 Mar 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
1,031
|
$16,166 | — | 31 Mar 2024 |
Institutional Holders of Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (LXEO) as of Q2 2024
As of 30 Jun 2024,
Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (LXEO) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,566,622 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, D1 Capital Partners L.P., Omega Fund Management, LLC, Novo Holdings A/S, BRAIDWELL LP, Vestal Point Capital, LP, and Woodline Partners LP.
This page lists
57
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
54
Q2 2024 holders
57
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.